Kalvista Pharmaceuticals Inc (KALV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 12-2015 | 04-2015 | 12-2014 | 04-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,846 | -7,226 | -13,359 | N/A | -5,678 |
| Depreciation Amortization | 913 | 38 | 438 | 50 | 27 |
| Accounts payable and accrued liabilities | 355 | 167 | 487 | N/A | 315 |
| Other Working Capital | -601 | 784 | 618 | 60 | 460 |
| Other Operating Activity | 3,316 | -131 | 563 | 130 | 18 |
| Operating Cash Flow | $-20,863 | $-6,368 | $-11,253 | $240 | $-4,858 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -659 | -125 | -159 | -1 | -18 |
| Other Investing Activity | -715 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-1,374 | $-125 | $-159 | $-1 | $-18 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | N/A | 2,208 | N/A | 546 |
| Debt Issued | 4,000 | N/A | 5,000 | N/A | 0 |
| Common Stock Issued | 68,063 | 8,661 | -972 | N/A | 17 |
| Other Financing Activity | 0 | 1 | -708 | 1,250 | 5,852 |
| Financing Cash Flow | $72,063 | $8,662 | $5,528 | $1,250 | $6,415 |
| Exchange Rate Effect | N/A | -124 | N/A | 0 | N/A |
| Beginning Cash Position | 3,897 | 481 | 9,781 | N/A | 8,242 |
| End Cash Position | 53,723 | 2,526 | 3,897 | N/A | 9,781 |
| Net Cash Flow | $49,826 | $2,045 | $-5,884 | $1,489 | $1,539 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,863 | -6,368 | -11,253 | 240 | -4,858 |
| Capital Expenditure | -659 | -125 | -159 | N/A | -18 |
| Free Cash Flow | -21,522 | -6,493 | -11,412 | 240 | -4,876 |